Impact of Pain and Symptom Burden on the Health-Related Quality of Life of Hemodialysis Patients

被引:220
作者
Davison, Sara N. [1 ]
Jhangri, Gian S. [2 ]
机构
[1] Univ Alberta, Dept Med, Div Nephrol & Immunol, Edmonton, AB, Canada
[2] Univ Alberta, Dept Publ Hlth Sci, Edmonton, AB, Canada
关键词
Pain; symptom burden; quality of lip; end-stage renal disease; dialysis; STAGE RENAL-DISEASE; FUNCTIONAL STATUS; ASSESSMENT SYSTEM; MEMBRANE FLUX; DIALYSIS; PREVALENCE; DEPRESSION; MORTALITY; CANCER; CARE;
D O I
10.1016/j.jpainsymman.2009.08.008
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Context. Dialysis patients experience tremendous symptom burden and substantial impaired health-related quality of life (HRQL). Objectives. We determined the association between symptom burden and HRQL in 591 hemodialysis patients. Methods. Patients completed the modified Edmonton Symptom Assessment System and the Kidney Dialysis Quality of Life Short Form at baseline and after six months. Results. There were no demographic, serological, or dialysis-related predictors for either HRQL or symptom burden. Pain, tiredness, lack of well-being, and depression were the only independent predictors of mental HRQL, accounting for 42.5% of the variation in the baseline mental health composite (MHC). Pain, fatigue, lack of wellbeing, and shortness of breath were the only independent predictors of physical HRQL, accounting for 38.5% of the variation in the baseline physical health composite (PHC). After follow-up, only changes in depression, anxiety, tiredness, and lack of appetite were independently associated with a change in MHC score, accounting for 48.7% of the variability. Only changes in pain, tiredness, and lack of appetite were independently associated with a change in PHC, accounting for 44.6% of the variability in the final multivariate regression model. No change in biochemical parameters predicted a change in either the MHC or the PHC. Conclusion. Symptom burden in end-stage renal disease was substantial and had a tremendous negative impact on all aspects of hemodialysis patients' HRQL. These patients, therefore, would likely benefit from the institution of programs to reduce symptom burden. J Pain Symptom Manage 2010;39:477-485. (C) 2010 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:477 / 485
页数:9
相关论文
共 49 条
[1]  
[Anonymous], 2007 ANN REP TREATM
[2]   A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients [J].
Beddhu, S ;
Bruns, FJ ;
Saul, M ;
Seddon, P ;
Zeidel, ML .
AMERICAN JOURNAL OF MEDICINE, 2000, 108 (08) :609-613
[3]   The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin [J].
Besarab, A ;
Bolton, WK ;
Browne, JK ;
Egrie, JC ;
Nissenson, AR ;
Okamoto, DM ;
Schwab, SJ ;
Goodkin, DA .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (09) :584-590
[4]  
Beusterien KM, 1996, J AM SOC NEPHROL, V7, P763
[5]   Quality of life measures in epilepsy - How well can they detect change over time? [J].
Birbeck, GL ;
Kim, S ;
Hays, RD ;
Vickrey, BG .
NEUROLOGY, 2000, 54 (09) :1822-1827
[6]   Differences in quality of life across renal replacement therapies: A meta-analytic comparison [J].
Cameron, JI ;
Whiteside, C ;
Katz, J ;
Devins, GM .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (04) :629-637
[7]   Longitudinal documentation of cancer pain management outcomes: A pilot study at a VA medical center [J].
Chang, VT ;
Hwang, SS ;
Kasimis, B .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2002, 24 (05) :494-505
[8]  
Curtin R.B., 2002, NEPHROLOGYNURSING J, V29, P574
[9]  
Curtin Roberta Braun, 2002, Nephrol Nurs J, V29, P567
[10]   Longitudinal validation of a modified Edmonton symptom assessment system (ESAS) in haemodialysis patients [J].
Davison, Sara N. ;
Jhangri, Gian S. ;
Johnson, Jeffrey A. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (11) :3189-3195